Skip to main content
The BMJ logoLink to The BMJ
letter
. 1993 Mar 6;306(6878):655–656. doi: 10.1136/bmj.306.6878.655-b

Gangliosides in neurological diseases.

C J Gibbs, G M McKhann, F S Walsh, R K Yu
PMCID: PMC1676943  PMID: 8379982

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Behan P. O., Haniffah B. A. Gangliosides and neurological diseases. BMJ. 1992 Nov 28;305(6865):1309–1310. doi: 10.1136/bmj.305.6865.1309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Figueras A., Morales-Olivas F. J., Capellà D., Palop V., Laporte J. R. Bovine gangliosides and acute motor polyneuropathy. BMJ. 1992 Nov 28;305(6865):1330–1331. doi: 10.1136/bmj.305.6865.1330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Mithen F. A., Ilyas A. A., Birchem R., Cook S. D. Effects of Guillain-Barré sera containing antibodies against glycolipids in cultures of rat Schwann cells and sensory neurons. J Neurol Sci. 1992 Oct;112(1-2):223–232. doi: 10.1016/0022-510x(92)90155-e. [DOI] [PubMed] [Google Scholar]
  4. Walsh F. S., Cronin M., Koblar S., Doherty P., Winer J., Leon A., Hughes R. A. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J Neuroimmunol. 1991 Oct;34(1):43–51. doi: 10.1016/0165-5728(91)90097-q. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES